Sfoglia per Autore "Germanidis, G."
Items 1-10 di 10
-
A comparative study of 10-Fr vs. 7-Fr straight plastic stents in the treatment of postcholecystectomy bile leak
Katsinelos, P.; Kountouras, J.; Paroutoglou, G.; Chatzimavroudis, G.; Germanidis, G.; Zavos, C.; Pilpilidis, I.; Paikos, D.; Papaziogas, B. (2008)Background: Biliary decompression is a key factor in the treatment of postcholecystectomy bile leak. However, the optimal size of the stent introduced by therapeutic endoscopic retrograde cholangiopancreatography (ERCP) ... -
Foxp3 Expression in Liver Correlates with the Degree but Not the Cause of Inflammation
Speletas, M.; Argentou, N.; Germanidis, G.; Vasiliadis, T.; Mantzoukis, K.; Patsiaoura, K.; Nikolaidis, P.; Karanikas, V.; Ritis, K.; Germenis, A. E. (2011)Patients with chronic viral hepatitis display increased expression of Foxp3 in liver, suggesting that Tregs expansion contributes to persistent infection. The purpose of this study was to elucidate whether the expression ... -
HBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORT
Goulis, L.; Akriviadis, E.; Karatapanis, S.; Deutsch, M.; Dalekos, G. N.; Raptopoulou-Gigi, M. P.; Drakoulis, C.; Mimidis, K.; Germanidis, G.; Nikolopoulou, V.; Chounta, A.; Bakalos, G.; Papatheodoridis, G. V. (2011) -
HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSIS
Goulis, I.; Akriviadis, E.; Karatapanis, S.; Deutsch, M.; Dalekos, G.; Raptopoulou-Gigi, M.; Mimidis, K.; Germanidis, G.; Triantos, C.; Drakoulis, C.; Chounta, A.; Tsoplou, F.; Zintzaras, E.; Bakalos, G.; Papatheodoridis, G. (2012) -
Liver FOXP3 and PD1/PDL1 expression is down-regulated in chronic HBV hepatitis on maintained remission related to the degree of inflammation
Germanidis, G.; Argentou, N.; Hytiroglou, P.; Vassiliadis, T.; Patsiaoura, K.; Germenis, A. E.; Speletas, M. (2013)Background and Aim: T cell expression of PD1 and inhibition of T effector cells by Foxp3(+)-T regulatory cells are among the most powerful mechanisms for achieving a balanced immune response. Our aim was to investigate, ... -
LIVER PD-1/PDL-1/PD-L2 MRNA EXPRESSION QUANTITATIVE ANALYSIS IN PATIENTS WITH CHRONIC HBV AND HCV HEPATITIS
Argentou, N.; Germanidis, G.; Vassiliadis, T.; Patsiaura, K.; Mantzoukis, K.; Ritis, K.; Eleftheriadis, D.; Evgenidis, N.; Nikolaidis, P.; Germenis, A. E.; Speletas, M. (2010) -
On treatment prediction of post-treatment sustained response to Peginterferon alfa-2a for HBeAg-negative Chronic Hepatitis B (CHB) patients using HBsAg and HBV DNA levels at weeks 12 and 24: PERSEAS cohort final results
Goulis, I.; Karatapanis, S.; Akriviadis, E. A.; Deutsch, M.; Dalekos, G. N.; Raptopoulou-Gigi, M.; Mimidis, K.; Germanidis, G.; Triantos, C. K.; Drakoulis, C.; Chounta, A.; Vafiadis, I.; Hatzis, G.; Gagalis, A.; Vlachogiannakos, J.; Zintzaras, E.; Koulouris, S.; Bakalos, G.; Papatheodoridis, G. V. (2013) -
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
Goulis, I.; Karatapanis, S.; Akriviadis, E.; Deutsch, M.; Dalekos, G. N.; Raptopoulou-Gigi, M.; Mimidis, K.; Germanidis, G.; Drakoulis, C.; Triantos, C.; Zintzaras, E.; Bakalos, G.; Papatheodoridis, G. (2015)Background & AimsWe assessed predictors of response in HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2a in routine clinical practice. MethodsNinety-five HBeAg-negative patients received ... -
Overexpression of SMAD7 protects liver from TGFb/Smad-mediated fibrogenesis
Argentou, N.; Germanidis, G.; Apostolou, E.; Vasiliadis, T.; Sideras, P.; Germenis, A. E.; Speletas, M. (2012) -
Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study
Manesis, E. K.; Vourli, G.; Dalekos, G.; Vasiliadis, T.; Manolaki, N.; Hounta, A.; Koutsounas, S.; Vafiadis, I.; Nikolopoulou, G.; Giannoulis, G.; Germanidis, G.; Papatheodoridis, G.; Touloumi, G. (2013)Background & Aims: Hepatitis D virus (HDV) has decreased in Europe, but recent reports indicate a rising trend. We report the epidemiological changes, clinical progress, and effect of treatment on the natural course of HDV ...